TellBio, Inc.

Biotech Andover, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Andover, MA
Street
19 Connector Rd
Zip
01810

Offering

Total offering
$1M
Amount sold
$1M
First sale
Sep 4, 2024
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
6

How this filing compares

Ranked #16 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.2× the median.

Other Massachusetts filings this week: Apnimed, Inc., BCV Emerge Fund V, L.P., LONG POINT INVESTORS, L.P., Neosoma, Inc., TA Realty Digital Real Estate Fund I, L.P.

Leadership

RICHARD PETERS — Executive Officer (also: Director)

GARY CROCKER — Director

BERNARD PETERS — Director

Filing details

TellBio, Inc. filed a Form D with the SEC on March 24, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts